Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company delivered its highest-ever quarterly revenue and EBITDA, marking a period of significant operational and strategic progress.
- A key positive development was the unfreezing of provisionally attached properties and fixed assets by income tax authorities, restoring full financial flexibility for expansion.
- The company continued its expansion strategy by operationalizing two new hospitals in New Delhi (Model Town, 300 beds) and Faridabad (Sector 20, 400 beds) and acquiring the 250-bed Shanti VED Hospital in Agra.
- The recent revision of Central Government Health Scheme (CGHS) rates, effective October 13, 2025, is expected to significantly enhance revenue realization and profitability across all hospitals.
- The company demonstrated a commitment to clinical excellence by adopting advanced technologies like the IntelliJoint software for robotic surgery and RapidAI for stroke detection, positioning itself among a select group of hospitals in North India.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.